Fundraising Fox
Omics Data Automation, Inc.
1 known investors
Find your way into Omics Data Automation, Inc.
Sign up to see every warm intro you have to Omics Data Automation, Inc.
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Omics Data Automation, Inc. team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Datma provides a federated data collaboration platform connecting health systems and labs with pharmaceutical companies for secure access to real-world clinical and molecular data. The platform enables pharma teams to access complete, de-identified datasets while allowing health systems and labs to maintain data control and generate revenue.
Investors · 1
Non-dilutive funding · 3 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| Department of Energy | Phase ISTTR | 2019 | $224.9K |
| National Science Foundation | Phase II | 2018 | $747.4K |
| National Science Foundation | Phase I | 2017 | $224.9K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Omics Data Automation, Inc. do?
- Datma provides a federated data collaboration platform connecting health systems and labs with pharmaceutical companies for secure access to real-world clinical and molecular data. The platform enables pharma teams to access complete, de-identified datasets while allowing health systems and labs to maintain data control and generate revenue.
- Who are Omics Data Automation, Inc.'s investors?
- Omics Data Automation, Inc.'s investors include TRANSFORMATION CAPITAL.